Jun20

What Atul Gawande will bring to the table as CEO of Amazon-Berkshire-JPM venture

Effective July 9, surgeon and author Atul Gawande, who has been outspoken about healthcare costs and quality, will take over as CEO of the new initiative.

Jun20

What Atul Gawande will bring to the table as CEO of Amazon-Berkshire-JPM venture

Effective July 9, surgeon and author Atul Gawande, who has been outspoken about healthcare costs and quality, will take over as CEO of the new initiative.

Jun20

Children’s Hospital of Philadelphia spinout developed medication error assessment tool

Bainbridge Health has raised about $3.5 million in seed funding to date, including $1.6 million from BioAdvance, Chestnut Street Ventures and, Children’s Hospital of Philadelphia.

Jun20

Can one new code spur a telehealth revolution?

The new CPT code 99091 allows physicians to bill for remote monitoring and this means significant new revenue for them and is clearly based on the return on investment for CMS and other payers when patients are remotely monitored for serious chronic co…

Jun19

Judge rules MD Anderson must pay $4.3M for HIPAA violations

The violations date back to three separate breach reports in 2012 and 2013, which involve the stealing of an unencrypted laptop and the loss of two unencrypted USB thumb drives.

Jun19

Unsurprisingly, physicians aren’t thrilled with their EHRs

A new survey of 521 licensed primary care physicians found 21 percent are somewhat dissatisfied with their current EHR and 13 percent are very dissatisfied with it.

Jun19

4 reasons why Walmart could Be Good for Health Care

The company clearly knows how to create efficiencies in areas where there previously were none, and analyze and activate on its abundance of consumer data. Those two qualities are in high demand in the health care sector.

Jun19

Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy

It’s the latest in a series of companies Roche has acquired to add services and technology to the Big Pharma’s drug development business, particularly in cancer treatment.